The year 2018 was epic for the Japanese pharmaceutical industry, largely because of the fundamental National Health Insurance (NHI) pricing reforms implemented in Ap...

There are just over 12 months to go until the EU Medical Device Regulation (MDR) enforcement deadline of May 2020. This is driving major efforts across the industry ...

In this article, Jim Robertson at Wynne Jones IP discusses how uncertainty surrounding a potential no-deal Brexit has created a deep chasm in opinion in relation to ...

It makes no sense that product data exists separately in ERP and RIM systems, compromising any efforts to improve efficiency through tighter inter-function collabora...

The new In Vitro Diagnostic Medical Devices Regulation (IVDR), EU 2017/746, was published in the Official Journal of the European Union in May 2017 with full impleme...

The rise of digital impacts the life sciences industry in multiple ways, says Emma Hyland at VEEVA. When it comes to content, it is fundamentally changing the relati...

Businesses throughout the pharmaceutical supply chain can now develop collaborative solutions that will fundamentally change the way the industry shares information....

The first germline transmission-capable transgenic mice were developed in the early 1980s in the laboratories of Frank Ruddle (Yale), Ralph Brinster (University of P...

The pharmaceutical landscape continues to evolve, with much R&D focusing on more specialised medicines. As the biological activity and specificity of the API in...

There are several methods for achieving cell disruption; however, high-pressure homogenisation (HPH) / microfluidisation is the standard approach for the scale of th...